Company intelligence / Profile preview
Molecular Express
Rancho Dominguez, California, United Statesmolecularexpress.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Molecular Express has developed advanced formulation services and the proprietary Molecular GPS™ platform for targeted drug delivery. The company has received SBIR funding from NIAID to develop a universal influenza vaccine in collaboration with Tulane University and UC Davis. No published clinical results are available; the program appears preclinical or early stage[6].
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- VaccineProteinSmall molecule
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Over 50 academic institutionsNIH/NIAIDTulane UniversityUC Davis California National Primate Research Center
Beyond the preview
Go deeper on Molecular Express.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Molecular Express.